Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Sep 14;29(11):2141–2148. doi: 10.1158/1055-9965.EPI-20-0520

Table 1.

Distribution of sarcoma cases by demographic and clinical characteristics, SEER 16 registries (2001 – 2015)

Total Sex, % Race,% Census Tract SES index, %
M F NHW NHB H AIAN/API Q1 Q2 Q3 Q4 Q5



All Ages at diagnosis
Bone sarcomas 7,067 57 43 63 8 22 7 17 19 20 21 24
Soft tissue sarcomas 48,348 51 49 64 12 15 9 17 18 20 22 24
(F −) sarcomas 17,391 59 41 67 9 17 8 16 18 20 21 24
(F +) sarcomas 13,662 53 47 58 14 20 8 17 19 20 21 23
Pediatric (<20 years)
Osteosarcoma 1,569 56 44 45 15 32 8 20 22 20 19 19
ES of bone 931 61 39 65 3 25 7 15 19 23 18 25
ARMS 489 54 46 45 17 28 10 18 22 18 19 23
Embryonal RMS 749 61 39 55 14 25 6 18 20 19 19 24
F/MF tumors 518 52 48 48 20 28 5 19 22 16 21 22
Synovial sarcoma 302 51 49 52 9 31 8 18 19 20 20 23
ES of soft tissue 352 56 44 57 5 32 7 16 19 22 21 22
(F −) sarcomas 2,078 56 44 46 14 32 8 20 22 19 20 20
(F +) sarcomas 2,762 56 44 55 10 27 8 17 20 20 19 23
Adult (20 – 65 years)
Osteosarcoma 1,203 56 45 54 13 23 9 21 18 20 19 21
ES of bone 450 64 36 73 4 19 5 18 20 19 20 23
Chondrosarcoma 1,699 53 48 72 6 17 5 15 18 20 22 25
Malignant chordoma 448 61 39 65 5 21 9 16 17 18 22 28
Other RMS 372 58 42 52 16 22 10 20 19 21 20 20
F/MF tumors 5,581 48 52 57 19 15 9 18 18 20 21 24
Synovial sarcoma 1,366 54 46 56 10 26 8 19 20 19 21 21
ES of soft tissue 442 52 48 62 5 22 12 18 21 22 20 20
MPNST 1,048 55 45 58 15 18 9 22 19 20 20 18
DSRCT 225 84 16 53 20 20 8 18 23 23 16 20
GIST 3,966 56 44 54 18 14 14 19 18 20 21 23
Leiomyosarcoma 6,036 27 73 59 16 17 9 17 19 19 23 22
Liposarcoma 4,796 60 40 63 9 20 9 16 18 20 22 25
Malignant vascular tumors 1,027 52 48 63 12 16 10 16 19 21 22 23
Epithelioid sarcoma 386 57 43 62 11 19 7 17 18 18 24 23
UPS 1,571 62 38 70 9 15 6 16 17 20 22 26
Unclassified sarcomas 2,218 54 46 61 13 17 9 19 18 20 20 22
(F −) sarcomas 9,114 58 42 64 10 18 8 17 18 20 21 24
(F +) sarcomas 9,284 52 48 57 15 19 9 18 19 20 21 23
Older Adult (65 + years)
Chondrosarcoma 537 53 47 83 3 10 4 13 18 18 24 27
Malignant chordoma 230 62 38 NR NR NR NR 12 17 16 23 32
Other RMS 237 43 57 74 9 9 8 14 17 19 24 26
F/MF tumors 1,455 50 50 74 7 11 8 12 19 20 23 26
MPNST 252 55 45 75 8 10 8 17 18 21 20 24
GIST 3,309 48 52 62 15 9 14 17 19 18 22 23
Leiomyosarcoma 3,220 41 59 75 11 9 6 16 19 20 21 24
Liposarcoma 2,721 62 38 74 5 12 9 14 18 20 23 26
Malignant vascular tumors 1,078 58 42 76 4 9 11 14 16 21 26 23
UPS 2,568 68 32 85 3 6 5 12 17 21 22 27
Unclassified sarcomas 2,064 55 45 80 7 8 6 14 18 20 23 25
(F −) sarcomas 6,199 62 38 79 5 9 7 13 18 21 23 26
(F +) sarcomas 1,616 51 49 73 9 11 8 15 19 17 24 25

ES = Ewing sarcoma; RMS = rhabdomyosarcoma; ARMS = Alveolar RMS; F/MF = Fibroblastic or Myofibroblastic; MPNST = Malignant peripheral nerve sheath tumor; DSRCT = Desmoplastic small round cell tumor; GIST = gastrointestinal stromal tumor; UPS = undifferentiated pleomorphic sarcoma; M= Male; F = Female; NH = Non-Hispanic; H = Hispanic; W = White; B = Black; AIAIN/API = American Indian, Alaskan native, Asian Pacific Islander; Q1 corresponds to lowest small-area SES quintile, Q5 corresponds to highest.NR = not reported due to insufficient sample sizes (< 5 cases in a cell).